Bayer, J&J win third US trial over Xarelto bleeding risk

Bayer, J&J win third US trial over Xarelto bleeding risk


A federal jury has cleared Bayer AG and Johnson & Johnson of liability in the third case to go to trial out of thousands of lawsuits claiming the drugmakers' blood thinner Xarelto led to severe internal bleeding. FILE PHOTO: The logo of Bayer AG is pictured at the Bayer Healthcare subgroup production plant in Wuppertal, Germany February 24, 2014.



from Biotech News